Patents by Inventor John GLEDHILL
John GLEDHILL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240151733Abstract: Epileptic seizures are difficult to diagnose and are often difficult to distinguish from several conditions with similar presentations, and therefore, diagnosis of seizures is often a long, expensive, and unreliable process. This invention provides biomarkers for identifying seizures and epilepsy, assays for measuring and assessing biomarker concentration, predictive models based on biomarkers and computational systems for detecting, assessing and diagnosing phasic and tonic changes associated with seizures and epilepsy in all clinical and healthcare settings. Diagnostic and treatment methods, systems, kits, and predictive models provided herein, provide quantitative and/or qualitative assessment in order to allow patients to proceed immediately to diagnostic and/or treatment protocols, and assess therapeutic treatment effectiveness.Type: ApplicationFiled: December 13, 2023Publication date: May 9, 2024Applicant: Cognizance Biomarkers, LLCInventors: Todd WALLACH, Elisa A. WAXMAN, John GLEDHILL, Richard ST. CLAIR, Elizabeth BRAND
-
Patent number: 11885817Abstract: Epileptic seizures are difficult to diagnose and are often difficult to distinguish from several conditions with similar presentations, and therefore, diagnosis of seizures is often a long, expensive, and unreliable process. This invention provides biomarkers for identifying seizures and epilepsy, assays for measuring and assessing biomarker concentration, predictive models based on biomarkers and computational systems for detecting, assessing and diagnosing phasic and tonic changes associated with seizures and epilepsy in all clinical and healthcare settings. Diagnostic and treatment methods, systems, kits, and predictive models provided herein, provide quantitative and/or qualitative assessment in order to allow patients to proceed immediately to diagnostic and/or treatment protocols, and assess therapeutic treatment effectiveness.Type: GrantFiled: May 16, 2018Date of Patent: January 30, 2024Assignee: Cognizance Biomarkers, LLCInventors: Todd Wallach, Elisa A. Waxman, John Gledhill, Richard St. Clair, Elizabeth Brand
-
Publication number: 20240002493Abstract: Epileptic seizures are difficult to diagnose and are often difficult to distinguish from several conditions with similar presentations, and therefore, diagnosis of seizures is often a long, expensive, and unreliable process. This invention provides biomarkers for identifying seizures and epilepsy, assays for measuring and assessing biomarker concentration, predictive models based on biomarkers and computational systems for detecting, assessing and diagnosing phasic and tonic changes associated with seizures and epilepsy in all clinical and healthcare settings. Diagnostic and treatment methods, systems, kits, and predictive models provided herein, provide quantitative and/or qualitative assessment in order to allow patients to proceed immediately to diagnostic and/or treatment protocols, and assess therapeutic treatment effectiveness.Type: ApplicationFiled: May 24, 2023Publication date: January 4, 2024Applicant: Cognizance Biomarkers, LLCInventors: Todd WALLACH, Elisa A. WAXMAN, John GLEDHILL, Richard ST. CLAIR, Elizabeth BRAND
-
Publication number: 20230251276Abstract: Epileptic seizures are difficult to diagnose and are often difficult to distinguish from several conditions with similar presentations, and therefore, diagnosis of seizures is often a long, expensive, and unreliable process. This invention provides biomarkers for identifying seizures and epilepsy, assays for measuring and assessing biomarker concentration, predictive models based on biomarkers and computer systems for detecting, assessing and diagnosing phasic and tonic changes associated with seizures and epilepsy in all clinical and healthcare settings. Diagnostic methods, kits and predictive models provided herein provide quantitative and/or qualitative assessment in order to allow patients to proceed immediately to diagnostic and/or treatment protocols, and assess therapeutic treatment effectiveness.Type: ApplicationFiled: January 30, 2023Publication date: August 10, 2023Applicant: Cognizance Biomarkers LLCInventors: Todd WALLACH, Peter CRINO, John POLLARD, Elizabeth BRAND, Maura STRAUMAN, Christopher HOLLENBEAK, Richard ST. CLAIR, Jeffrey BOTBYL, John GLEDHILL
-
Patent number: 11692030Abstract: Epileptic seizures are difficult to diagnose and are often difficult to distinguish from several conditions with similar presentations, and therefore, diagnosis of seizures is often a long, expensive, and unreliable process. This invention provides biomarkers for identifying seizures and epilepsy, assays for measuring and assessing biomarker concentration, predictive models based on biomarkers and computational systems for detecting, assessing and diagnosing phasic and tonic changes associated with seizures and epilepsy in all clinical and healthcare settings. Diagnostic and treatment methods, systems, kits, and predictive models provided herein, provide quantitative and/or qualitative assessment in order to allow patients to proceed immediately to diagnostic and/or treatment protocols, and assess therapeutic treatment effectiveness.Type: GrantFiled: November 15, 2019Date of Patent: July 4, 2023Assignee: Cognizance Biomarkers, LLCInventors: Todd Wallach, Elisa A. Waxman, John Gledhill, Richard St. Clair, Elizabeth Brand
-
Patent number: 11598782Abstract: Epileptic seizures are difficult to diagnose and are often difficult to distinguish from several conditions with similar presentations, and therefore, diagnosis of seizures is often a long, expensive, and unreliable process. This invention provides biomarkers for identifying seizures and epilepsy, assays for measuring and assessing biomarker concentration, predictive models based on biomarkers and computer systems for detecting, assessing and diagnosing phasic and tonic changes associated with seizures and epilepsy in all clinical and healthcare settings. Diagnostic methods, kits and predictive models provided herein provide quantitative and/or qualitative assessment in order to allow patients to proceed immediately to diagnostic and/or treatment protocols, and assess therapeutic treatment effectiveness.Type: GrantFiled: June 4, 2020Date of Patent: March 7, 2023Assignee: Cognizance Biomarkers, LLCInventors: Todd Wallach, Peter Crino, John Pollard, Elizabeth Brand, Maura Strauman, Christopher Hollenbeak, Rich St. Clair, Jeffrey Botbyl, John Gledhill
-
Publication number: 20220178948Abstract: Epileptic seizures are difficult to diagnose and are often difficult to distinguish from several conditions with similar presentations, and therefore, diagnosis of seizures is often a long, expensive, and unreliable process. This invention provides biomarkers for identifying seizures and epilepsy, assays for measuring and assessing biomarker concentration, predictive models based on biomarkers and computational systems for detecting, assessing and diagnosing phasic and tonic changes associated with seizures and epilepsy in all clinical and healthcare settings. Diagnostic and treatment methods, systems, kits, and predictive models provided herein, provide quantitative and/or qualitative assessment in order to allow patients to proceed immediately to diagnostic and/or treatment protocols, and assess therapeutic treatment effectiveness.Type: ApplicationFiled: May 16, 2018Publication date: June 9, 2022Applicant: EVOGEN, INC.Inventors: Todd WALLACH, Elisa A. WAXMAN, John GLEDHILL, Richard ST. CLAIR, Elizabeth BRAND
-
Publication number: 20210199672Abstract: Epileptic seizures, NES, NS, PNES or NEE are difficult to diagnose and are often difficult to distinguish from several conditions with similar presentations, and therefore, diagnosis of seizures is often a long, expensive, and unreliable process. This invention provides biomarkers for identifying and monitoring seizures and epilepsy, ES, NES, NS, PNES or NEE assays for measuring and assessing biomarker concentration, predictive models based on biomarkers and computational systems for diagnosing, monitoring and predicting therapeutic efficacy associated with seizures and epilepsy, ES, NES, NS, PNES or NEE in all clinical and healthcare settings. Diagnostic and treatment methods, systems, kits, and predictive models provided herein, provide quantitative and/or qualitative assessment in order to allow patients to proceed immediately to diagnostic and/or treatment protocols, and assess therapeutic treatment effectiveness.Type: ApplicationFiled: May 29, 2019Publication date: July 1, 2021Applicant: EVOGEN, INC.Inventors: Todd WALLACH, John GLEDHILL, Richard ST.CLAIR, Elizabeth BRAND
-
Publication number: 20200324741Abstract: A jack stabilizing apparatus that is operably coupled intermediate a scissor jack and a portion of a frame of a recreational trailer and is configured to substantially inhibit movement of the recreational trailer ensuing being lifted by the scissor jack. The jack stabilizing apparatus includes a coupling member that is secured to the scissor jack. A frame attachment member is operably coupled to the frame of the recreational trailer. A support arm is intermediate the coupling member and the frame attachment member and operably coupled to each. The support member includes a first portion and a second portion that are slidably coupled so as to provide length adjustment thereof. The frame attachment member is provided in several alternative embodiments so as to be operably coupled to either a box style frame or an i-beam style frame of a recreational trailer.Type: ApplicationFiled: April 15, 2019Publication date: October 15, 2020Inventor: Mike John Gledhill
-
Publication number: 20200299377Abstract: Epileptic seizures are difficult to diagnose and are often difficult to distinguish from several conditions with similar presentations, and therefore, diagnosis of seizures is often a long, expensive, and unreliable process. This invention provides biomarkers for identifying seizures and epilepsy, assays for measuring and assessing biomarker concentration, predictive models based on biomarkers and computational systems for detecting, assessing and diagnosing phasic and tonic changes associated with seizures and epilepsy in all clinical and healthcare settings. Diagnostic and treatment methods, systems, kits, and predictive models provided herein, provide quantitative and/or qualitative assessment in order to allow patients to proceed immediately to diagnostic and/or treatment protocols, and assess therapeutic treatment effectiveness.Type: ApplicationFiled: November 15, 2019Publication date: September 24, 2020Applicant: EVOGEN, INC.Inventors: Todd WALLACH, Elisa A. WAXMAN, John GLEDHILL, Richard ST. CLAIR, Elizabeth BRAND
-
Publication number: 20200300871Abstract: Epileptic seizures are difficult to diagnose and are often difficult to distinguish from several conditions with similar presentations, and therefore, diagnosis of seizures is often a long, expensive, and unreliable process. This invention provides biomarkers for identifying seizures and epilepsy, assays for measuring and assessing biomarker concentration, predictive models based on biomarkers and computer systems for detecting, assessing and diagnosing phasic and tonic changes associated with seizures and epilepsy in all clinical and healthcare settings. Diagnostic methods, kits and predictive models provided herein provide quantitative and/or qualitative assessment in order to allow patients to proceed immediately to diagnostic and/or treatment protocols, and assess therapeutic treatment effectiveness.Type: ApplicationFiled: June 4, 2020Publication date: September 24, 2020Inventors: Todd WALLACH, Peter CRINO, John POLLARD, Elizabeth BRAND, Maura STRAUMAN, Christopher HOLLENBEAK, Rich ST. CLAIR, Jeffrey BOTBYL, John GLEDHILL
-
Publication number: 20190011461Abstract: Epileptic seizures are difficult to diagnose and are often difficult to distinguish from several conditions with similar presentations, and therefore, diagnosis of seizures is often a long, expensive, and unreliable process. This invention provides biomarkers for identifying seizures and epilepsy, assays for measuring and assessing biomarker concentration, predictive models based on biomarkers and computer systems for detecting, assessing and diagnosing phasic and tonic changes associated with seizures and epilepsy in all clinical and healthcare settings. Diagnostic methods, kits and predictive models provided herein provide quantitative and/or qualitative assessment in order to allow patients to proceed immediately to diagnostic and/or treatment protocols, and assess therapeutic treatment effectiveness.Type: ApplicationFiled: January 4, 2017Publication date: January 10, 2019Applicant: EVOGEN, INC.Inventors: Todd WALLACH, Peter CRINO, John POLLARD, Elizabeth BRAND, Maura STRAUMAN, Christopher HOLLENBEAK, Rich ST. CLAIR, Jeffery BOTBYL, John GLEDHILL